CVS Caremark bear steps up

|About: CVS Health Corporation (CVS)|By:, SA News Editor

Standpoint Research initiates coverage on CVS Caremark (CVS -0.2%) with a dour Sell rating due to valuation.

The investment firm has a price target of $62 on shares of the drugstore operator.